DCGO - DocGo Inc.
DocGo NASDAQ: DCGO Chief Executive Officer Lee Bienstock outlined the company's transition away from COVID-related, migrant and emergency-response programs and toward its “evergreen” medical transportation and mobile health businesses during a presentation at the 21st Annual Needham Technology, Media, and Consumer Conference.
DocGo Inc. (DCGO) Q1 2026 Earnings Call Transcript
DocGo NASDAQ: DCGO reported first-quarter revenue of $75.6 million and an adjusted EBITDA loss of $10.2 million, as executives pointed to accelerating demand in virtual care, medical transportation and mobile health services while acknowledging pressure from fuel costs and labor-related investments.
DocGo Inc. (DCGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.09 per share a year ago.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenue for the first quarter of 2026 was $75.6 million, compared to $96.0 million in the first quarter of 2025. This decline was entirely due to the wind-down of migrant-related programs,.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will deliver a company presentation at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, at 11:45 – 12:25 PM Eastern Time, and will be participating in 1x1 meetings at this event. A webcast of the presentation will be available on the investo.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31, 2026 after the markets close on Monday, May 11, 2026. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, May 11, 2026 5:00 p.m.
Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have earned an average rating of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company.
DocGo (NASDAQ: DCGO - Get Free Report) and CochLear (OTCMKTS:CHEOY - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Analyst Recommendations This is a summary of recent ratings and
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor, and the Company is one of only four honorees in the healthcare providers and ser.
DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
DocGo Inc. (DCGO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to earnings of $0.04 per share a year ago.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared to $120.8 million in the fourth quarter of 2024. This decline was entirely due to the wind-down of mig.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
DocGo (NASDAQ: DCGO) executives and TD Cowen healthcare facilities and services analyst Charles Rhyee outlined the company's strategy to deliver "proactive healthcare at any address," positioning its mobile health and medical transportation platform as a way to improve access, reduce unnecessary emergency department utilization, and support a healthcare system facing capacity constraints and rising chronic disease.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2025, after the markets close on Monday, March 16, 2025. Management will also host a conference call to discuss these results and its outlook for 2026 at 5:00 p.m. ET on that day. Conference call and we.
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the TD Cowen 46th Annual Health Care Conference on Monday, March 2nd, and will deliver a presentation at 9:10 AM ET on that day. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is lea.
DocGo Inc. (NASDAQ: DCGO - Get Free Report) has earned a consensus rating of "Hold" from the seven analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its virtual care division, SteadyMD, is undertaking an immediate expansion of its clinical workforce, with plans to increase clinical staff by up to 50% over the coming weeks. The hiring initiative is driven by accelerating demand from its customer roster of top consumer, healthcare, and digital wellness.
DocGo Inc. (NASDAQ: DCGO - Get Free Report) has earned an average recommendation of "Hold" from the seven analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month